Home > Insider Trading > Filing (0001209191-13-038501)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
875320	Vertex Pharmaceuticals Inc / Ma	VRTX	Pharmaceutical Preparations (2834)	043039129

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1432895	Joseph Wayne Riley	C/O Vertex Pharmaceuticals Incorporated 130 Waverly St. Cambridge MA 02139		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2013-07-29	10,000	$33.89	10,000	No	4	M	Direct
Common Stock	Disposition	2013-07-29	9,700	$80.08	300	No	4	S	Direct
Common Stock	Disposition	2013-07-29	100	$81.18	200	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option	Disposition	2013-07-29	10,000	$0.00	10,000	$33.89

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
20,000		2020-07-08	No	4	M	Direct

Footnotes

Transaction made pursuant to Dr. Riley's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $80.08 (range $80.00 to $80.92).
Dr. Riley undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
The option vests in 16 quarterly installments from 07/09/2010.